Progress in study of antiviral effect of chronic hepatitis B
10.3969/j.issn.1006-0111.2015.06.022
- VernacularTitle:慢性乙型肝炎的抗病毒研究进展
- Author:
Yue CAO
1
;
Qijun QIAN
Author Information
1. 福建医科大学第一临床医学院
- Keywords:
hepatitis B virus;
nucleoside analogues;
interferons;
therapeutic vaccines;
biological immunotherapy
- From:
Journal of Pharmaceutical Practice
2015;(6):561-565
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B is a worldwide infectious diseases caused by hepatitis B virus (HBV) .HBV infection is an important reason for liver cirrhosis and liver cancer in our country .Currently ,the interferon and nucleoside analogs antiviral drugs (nucleotides) is widely used in clinical practice .These drugs inhibit the replication of the virus and disease development to a certain extent ,but not fundamentally eliminate the virus .Various therapeutic vaccines have also made certain curative effect in anti HBV ,but the effect is not perfect clinically .At present ,many research results demonstrate that biological immu-notherapy can successfully eliminate HBV virus in the body , therefore it has brought a new hope for the treatment of hepatitis B .
